Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company uniquely focused on plastic surgeons. The Company mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work and care for their patients. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.

*Data on file

Presentations



Nasdaq: SIEN

Stock Quote: NASD

$7.20 +0.22
Volume 412,065
Previous Close 6.98
Intraday High 7.24
Intraday Low 6.96
Pricing delayed 20 minutes
Price Change % Change +3.08% 52 Week High 8.93 52 Week Low 2.20 Today's Open 6.96 May 07, 2021 04:00 PM

Investor Contact

Sientra Investor Relations
805-679-8885